Legal Disclaimer
Merck has carefully compiled the contents on this website and according
to the current state of knowledge. Access to and use of this website as
well as websites related or connected to this by links are at the user’s own
risk. Damage and warranty claims arising from missing or incorrect data are
excluded.
Merck bears no responsibility or liability for damage of any kind, also for
indirect or consequential damage resulting from access to or use of this website
or websites related or connected to this by links.
Merck is the sole owner of all user rights related to the contents of the websites
(in particular information, materials, programs), unless otherwise indicated. Without
the written permission of Merck it is prohibited to integrate the protected contents
published on these websites into other programs or other websites or to use them by
any other means.
General Company Information
Merck KGaA
Frankfurter Strasse 250
64293 Darmstadt
Germany
Phone: +49 6151 72-0
Telefax: +49 6151 72-2000
www.merck.de
General e-mail address for Internet contacts: erbitux@cca-uk.com
Legal form: Partnership limited by shares
Commercial Register: AG Darmstadt HRB 6164
Registered Office: Darmstadt
Chairman of the Supervisory Board: Professor Dr. Rolf Krebs
Executive Board and General Partners:
Karl-Ludwig Kley (Chairman)
Michael Becker
Bernd Reckmann
Elmar Schnee
VAT Identification Number: DE 811850788
Competent Governmental Authority:
Regierungspräsidium Darmstadt (Germany)
|
Visual and video library
Download a comprehensive range of visuals and videos.
Click hereThe KRAS Test
Get more information about the KRAS test procedure in this video.
Click hereErbitux - Mode of Action
Get more information about Erbitux mode of action in this new video.
Click here |